Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
10/2008
10/22/2008CN101291913A Azinyl-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands
10/22/2008CN101289446A Polarity sensitive fluorescent probe suitable for marking sulfhydryl, preparation method thereof and applications
10/22/2008CN101289445A Aniline quinazoline derivatives, preparation method and uses thereof
10/22/2008CN101289444A Pyrimidine derivate and medicinal use thereof
10/22/2008CN100427486C Novel benzimidazole derivatives
10/22/2008CN100427481C An arylether kind compound and its preparation and application
10/22/2008CN100427469C Quinoline derivatives as neutrophil elastase inhibitors and their use
10/22/2008CN100427093C 4(2-butylamino)-2,7-dimethyl-8-(2-methyl(-6-methoxyp-3-yl)pyrazolo-[1,5-A]-1,3,5-triazine as corticotropin releasing factor receptor
10/21/2008US7439371 N-methyl-2-(3-{[4-(4-methyl-piperazin-1-yl)-phenylamino]-methylene}-2-oxo-2,3-dihydro-1H-indol-6-ylsulfanyl)-benzamide for modulating tyrosine kinase signal transduction to regulate, modulate and/or inhibit abnormal cell proliferation
10/21/2008US7439370 Imidazole derivatives, their preparation and their use as intermediates for the preparation of pharmaceutical compositions and pesticides
10/21/2008US7439363 Substituted indazoly(indoly)maleimide derivatives as kinase inhibitors
10/21/2008US7439361 A2a receptor antagonists; Parkinson's disease
10/21/2008US7439342 Thrombopoietin mimetics
10/21/2008US7439263 e.g. 1-({[9-(hydroxymethyl)-3-oxaspiro[5.5]undec-9-yl]amino}acetyl)-2-pyrrolidinecarbonitrile; dipeptidyl-peptidase IV inhibitor; antidiabetic, hypoglycemic agent; non-insulin dependent diabetes, obesity
10/21/2008US7439258 Viral polymerase inhibitors
10/21/2008CA2368823C Use of dopamine d3 receptor ligands for producing medicaments for treating kidney disorders
10/21/2008CA2146707C Substituted n-heteroaroylguanidines as inhibitors of na+/h+ exchange
10/16/2008WO2008124703A2 Development of molecular imaging probes for carbonic anhydrase-ix using click chemistry
10/16/2008WO2008124614A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
10/16/2008WO2008124083A2 Aurora kinase modulators and method of use
10/16/2008WO2008124075A1 Novel 2,3-benzodiazepine derivatives and their use as antipsychotic agents
10/16/2008WO2008123540A2 Organic electroluminescent device
10/16/2008WO2008123207A1 Ornithine derivative
10/16/2008WO2008123189A1 Compound for organic electroluminescent device and organic electroluminescent device
10/16/2008WO2008122810A1 Phthalazinone derivatives and their use as medicament to treat cancer
10/16/2008WO2008122667A2 Ureylene derivatives
10/16/2008WO2008122356A1 Cardiovascular agents
10/16/2008WO2008122329A1 Uv-filter compounds
10/16/2008WO2008086122A3 Imidazole derivatives as kinesin spindle protein inhibitors (eg-5)
10/16/2008WO2008079988A3 Quinazolines for pdk1 inhibition
10/16/2008WO2008076883A3 Triazine derivatives and their therapeutical applications
10/16/2008WO2008035360A3 Novel crystalline forms of candesartan cilexetil, candesartan, tritylated candesartan and tritylated candesartan cilexetil
10/16/2008WO2007105058A8 Pyrazole compounds
10/16/2008WO2006015259A3 Compounds and compositions as modulators of steroid hormone nuclear receptors
10/16/2008US20080255368 Tgf-ß Gene Expression Inhibitor
10/16/2008US20080255362 Cyclic amide derivative, and its production and use
10/16/2008US20080255352 Cyclic amide derivative, and its production and use
10/16/2008US20080255350 Substituted aza-indoles as inhibitors of poly(adp-ribose) polymerase (parp)
10/16/2008US20080255345 IRNA Agents Targeting CCR5 Expressing Cells And Uses Thereof
10/16/2008US20080255218 N-benzylamino cyclic thioureas; obesity and related disorders; (N-(3-{(4S)-1-[(1S)-2-(benzylamino)-1-methylethyl]-3-[2-(3-fluorophenyl)ethyl]-2-thioxoimidazolidin-4-yl}propyl)guanidine
10/16/2008US20080255216 Diaryltriazoles as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase-1
10/16/2008US20080255207 5-Thioxo-1,5-Dihydro-2H-Pyrrol-2-One Derivatives As Liver X Receptor Modulators
10/16/2008US20080255191 Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
10/16/2008US20080255182 Certain chemical entities, compositions, and methods
10/16/2008US20080255169 4'-Fluoro-biphenyl-3-sulfonic acid benzo[1,3]dioxol-5-ylamide, for example; for use as an alpha 2 beta 1 integrin I domain inhibitor; use as a medicament for treating thrombosis and cancer spread
10/16/2008US20080255154 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: N-methyl-5-[4-(1-{[3-oxo-1'H,3H-spiro[2-benzofuran-1,3'-pyrrolidin]-1'-yl]carbonyl}cyclopropyl)phenyl]pyridine-2-carboxamide; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; diabetes
10/16/2008US20080255143 Inhibitors of Akt Activity
10/16/2008US20080255140 2-(N'-2-amino-3,4-dioxocyclobutenyl)-N-piperazinyl)-pyrimidine-5-hydroxamic acid derivatives; antiproliferative, anticarcinogenic, and antitumor agents; psoriasis; skin, respiratory system, psychological, and genetic disorders; transplant rejection; Alzheimer's and Parkinson's disease; vision defects
10/16/2008US20080255136 Pyrrolidones with anti-hiv activity
10/16/2008US20080255126 Inhibitors of post-proline cleaving proteases
10/16/2008US20080255118 Cyanopyrimidinones
10/16/2008US20080255117 Sulfonyltryptophanols
10/16/2008US20080255112 Pyrimidine-Substituted Benzimidazole Derivatives as Protein Kinase Inhibitors
10/16/2008US20080255109 Antigonadotrophins; breast and prostate cancer, endometriosis, benign prostate hyperplasia; regulation of fertility; 4-(3-Chloro-4-{{(4-chloro-benzenesulfonyl)-methyl-amino]-methyl}-thiophene-2-carbonyl)-3,4-dihydro-2H-benzo[1,4]oxazine-2carboxylic acid (3-methyl-[1,2,4]oxadiazol-5-ylmethyl)-amide
10/16/2008US20080255102 1-(2,3-dihydro-4H-1,4-benzoxazin-4-yl)-3-(methylamino)-1-phenylpropan-2-ol; fluctuations of sex steroid lelels; monoamine reuptake modulator; antidepressant, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue and fibromylagia syndrome, stress and urinary incontinence
10/16/2008US20080254384 Photosensitive composition, lithographic printing plate precursor, lithographic printing method, and novel cyanine dyes
10/16/2008CA2683682A1 Phthalazinone derivatives and their use as medicament to treat cancer
10/16/2008CA2683434A1 Development of molecular imaging probes for carbonic anhydrase-ix using click chemistry
10/16/2008CA2683433A1 Nitro-imidazole hypoxia imaging agents
10/16/2008CA2681861A1 Ornithine derivative
10/15/2008EP1980559A1 Cardiovascular agents
10/15/2008EP1980558A1 Polycationic monochromophoric compounds of hydrazone type, dyeing compositions comprising same and dyeing method
10/15/2008EP1979344A2 N-(2,3-difluorophenyl)-2-[4-({7-methoxy-5-[(2r)-piperidin.-2-ylmethoxy]quinazolin-4-yl}amino)-1h-pyrazol-1-yl]acetamide and n-(2,3-difluorophenyl)-2-[4-({7-ethoxy-5-[(2r)-piperidin.-2-ylmethoxy]quinazolin-4-yl}amino)-1h-pyrazol-1-yl]acetamide for use in the treatment of disease
10/15/2008EP1979339A2 Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
10/15/2008EP1979338A1 Cis-4, 5-biaryl-2-heterocyclic-imidazolines as mdm2 inhibitors
10/15/2008EP1979331A1 Trisubstituted amine compounds as inhibitors of -cholesteryl ester transfer protein cetp
10/15/2008EP1979329A2 4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as jak-2 modulators and methods of use
10/15/2008EP1979328A1 Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
10/15/2008EP1979326A1 Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
10/15/2008EP1979325A1 Morpholino pyrimidine derivatives and their use in therapy
10/15/2008EP1979324A2 Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer's disease, neurodegeneration and dementia
10/15/2008EP1979315A2 Methods for treating hepatitis c
10/15/2008EP1979314A2 Indole sulfonamide modulators of progesterone receptors
10/15/2008EP1660455B1 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
10/15/2008EP1587585B1 Acylsulfonamide compounds as inhibitors of rna-dependent rna (viral) polymerases
10/15/2008EP1444202B1 Novel metalloproteinase inhibitors
10/15/2008EP1375486B1 Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity
10/15/2008EP1373257B9 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
10/15/2008EP1308439B1 Proline derivatives and use thereof as drugs
10/15/2008EP1142872B1 Aromatic heterocycle compounds having hiv integrase inhibiting activities
10/15/2008CN101287726A Pyrrolidine and piperidine acetylene derivatives for use as MGLUR5 antagonists
10/15/2008CN101287724A Solid salt forms of a pyrrole substituted 2-indolinone
10/15/2008CN101287722A Substituted piperazines as metabotropic glutamate receptor antagonists
10/15/2008CN101287721A 酰肼化合物和其杀虫用途 Hydrazide compounds and their insecticidal use
10/15/2008CN101287715A Amide derivatives
10/15/2008CN101287713A Organic compound, charge-transporting material, composition for charge-transporting material and organic electroluminescent device
10/15/2008CN101284819A Fused pyridazine derivative compounds and drugs containing these compounds as the active ingredient
10/15/2008CN101284814A Method for producing acrylonitrile compound
10/15/2008CN100425608C Acyloxypyrrolidine derivatives, preparation thereof and application thereof in therapeutic
10/14/2008US7435833 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
10/14/2008US7435832 Preparing an anhydrous crystal of a malic acid salt of N-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide by reacting the acid and amine in a solvent and crystallizing under various process conditions
10/14/2008US7435830 Bicyclic and bridged nitrogen heterocycles
10/14/2008US7435829 Pyrazolyl-substituted heterocycles and their use as phytosanitary products
10/14/2008US7435824 Prodrugs of potassium channel inhibitors
10/14/2008US7435823 2,3-Dihydro-4H-1,4-benzoxazine derivatives containing an optionally fused pyridine or pyrimidine ring; 7-((6,7-bis(methyloxy)-4-quinolinyl)oxy)-N-phenyl-2,3-dihydro-4H-1,4-benzoxazine-4-carboxamide; kinase inhibitors; inflammation, angiogenesis and cancer
10/14/2008US7435814 N4-(1,4-Benzoxazin-6-yl)-5-fluoro-N2-[3-(N-methylamino)carbonylmethyleneoxyphenyl]-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors
10/14/2008US7435753 1-aryl-4-cyclopropylpyrazoles with at least one fluorine attached to the cyclopropyl ring; Coupling of an aryldiazonium salt with a 2,3-dicyano-3-cyclopropyl propanoate; parasiticides; fleas; Extended duration of action for at least 28 days
10/14/2008US7435734 Such as N-(2-ethoxybenzyl)-5-hydroxy-1-methyl-2-(4-methylphenyl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide; inhibitors of HIV replication; with other HIV/AIDS antivirals, anti-infectives, immunomodulators, antibiotics or vaccines; AIDS
10/14/2008US7435728 Pyrazole derivatives
10/14/2008CA2309328C Cyclic amine derivatives and their use as drugs
1 ... 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 ... 626